DataMeds AI, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
DataMeds AI, Inc. (MEDS) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 200.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-08-17
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month 200.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month |
|---|---|
| 2026-06-30 | 200.00K shares 10-Q · filed 2026-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |